
Imvax Advances a New Approach to Personalized Cancer Immunotherapy
**Sponsored Content**
Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.
Want to join the ABTA virtual 50 mile Facebook Challenge? Check it out here.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
**Sponsored Content**
Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.
**Sponsored Content**
An acoustic neuroma diagnosis comes with complex treatment decisions. Read why a multidisciplinary care team is crucial for your long-term recovery.
**Sponsored Content**
After processing the initial shock of her GBM diagnosis at 36, Jeanneane M. created a “coping routine” that’s helped her get through difficult days and hold onto hope for her future.
**Sponsored Content** Meet one neurosurgeon who hopes to transform brain tumor care by bringing state-of-the-art technology to his homeland of Puerto Rico.
In his own words, caregiver and musician Scott Ingersoll shares how he used music to channel his wife’s journey battling astrocytoma.
**Sponsored Content**
See how a cutting-edge imaging solution by Medexus Pharma is revolutionizing treatment outcomes for GBM patients.
From innovations in brain surgery to tips for living your best life, get the top takeaways from the 2022 National Conference.
**Sponsored Content**
Chris traveled across the country for a minimally invasive “keyhole” procedure to remove his large meningioma. Read why he chose Dr. Daniel Kelly at Pacific Neuroscience Institute (PNI) for his brain surgery.
What started as a small golf outing to remember a beloved friend lost to brain cancer has blossomed into 25 years of a shining legacy and more than $660,000 for crucial brain tumor research.
The need for better brain tumor treatments and more help for patients is greater than ever. Brain tumors are still very hard to treat because of something called the blood-brain barrier, which makes it tough for medicine to reach the tumor. Brain tumor patients need more options.
That’s why we’re meeting hope head on—because donations lead to research, research leads to better treatments, and better treatments bring us closer to a cure.